Health technology assessment methodology in metastatic renal cell carcinoma.,Nature Reviews Urology

当前位置： X-MOL 学术 › Nat. Rev. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Health technology assessment methodology in metastatic renal cell carcinoma.
Nature Reviews Urology ( IF 12.1 ) Pub Date : 2020-01-01 , DOI: 10.1038/s41585-019-0257-4
Ambica Parmar ₁ , Kelvin K W Chan _{1,

2}

Affiliation

Cancer care is currently experiencing rapid development in novel therapeutics, with an associated rise in treatment costs. These changes not only create a critical challenge for therapeutic decision-making but also highlight the need to prioritize therapies of high clinical and economic value. Health technology assessment methodology is a novel approach that could help guide value-based decision-making.

中文翻译：